SNAPC1: A Potential Drug Target and Biomarker (G6617)

Target Name: SNAPC1

NCBI ID: G6617

SNAPC1

SNAPC1: A Potential Drug Target and Biomarker

SnRNA-activating protein complex subunit 1 (SNAPC1) is a protein that plays a critical role in cellular processes such as gene expression, DNA replication, and repair. It is a key component of the SNAPC complex, which is a protein-protein interaction network that regulates various cellular processes. SNAPC1 has been identified as a potential drug target and biomarker due to its unique structure and function.

SNAPC1 is a 21-kDa protein that consists of two subunits, SNAPC1伪 and SNAPC1尾. The N-terminus of SNAPC1伪 contains a conserved domain that is similar to other SNAPC subunits, while the C-terminus contains a unique domain that is specific to SNAPC1. The SNAPC1伪 subunit has four conserved potential binding sites, including a N-terminal alpha-helices, a central 尾-sheet, and two C-terminal T-spots. These conserved domains are involved in the formation of the SNAPC complex and in SNAPC1's function as a protein-protein interaction regulator.

SNAPC1's unique structure and function make it an attractive drug target. Its conserved domains make it a good target for small molecules, which can modulate its activity and disrupt its function. Additionally, its role as a protein-protein interaction regulator makes it a potential target for drugs that target protein-protein interactions. SNAPC1 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and DNA replication. Therefore, modulating its activity could be a potential strategy for treating various diseases.

SNAPC1 has also been identified as a potential biomarker for certain diseases. Its role in cellular processes makes it a potential target for drugs that affect cellular processes. For example, SNAPC1 has been shown to be involved in the regulation of cell apoptosis, which is a critical process that helps the body eliminate damaged or dysfunctional cells. Therefore, modulating SNAPC1's activity could be a potential strategy for treating certain types of cancer.

In conclusion, SNAPC1 is a unique protein that plays a critical role in cellular processes. Its conserved domains and role as a protein-protein interaction regulator make it an attractive drug target. Additionally, its potential role as a biomarker for certain diseases makes it an important target for researchers and clinicians. Further research is needed to fully understand the role of SNAPC1 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Small Nuclear RNA Activating Complex Polypeptide 1

Functions: Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box

The "SNAPC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNAPC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets